Hepatect Cp

Hepatect Cp is a prescription‑only solution for injection that contains human hepatitis B immunoglobulin as its active ingredient. It is supplied as an intravenous preparation and is used in the European market to provide passive immunity against hepatitis B virus infection following exposure.

Hepatect Cp is indicated for post‑exposure prophylaxis against hepatitis B virus. It is administered to individuals who have been exposed to hepatitis B through contaminated blood or body fluids.

- Prevention of hepatitis B infection after accidental needle sticks or occupational exposure. - Post‑exposure prophylaxis for household contacts of hepatitis B carriers. - Supplementary protection for newborns of hepatitis B‑positive mothers when vaccine alone is insufficient. - Use in patients with compromised immune response who cannot mount adequate vaccine protection. - Administration to travelers at high risk of hepatitis B exposure in endemic regions.

Side effects of Hepatect Cp may vary in frequency and severity. Patients should be monitored for any adverse reactions during and after infusion.

Common: - Mild fever or chills during infusion. - Headache or dizziness. - Nausea or mild gastrointestinal discomfort. - Localized redness or swelling at the injection site.

Serious: - Severe allergic reaction (anaphylaxis) with difficulty breathing. - Acute hemolysis leading to dark urine and fatigue. - Thrombotic events such as deep vein thrombosis. - Renal impairment manifested by reduced urine output. - Severe hypotension or shock during infusion.

Before using Hepatect Cp, healthcare providers should consider several safety factors to minimize risk.

- Verify patient’s hepatitis B serology and vaccination history. - Assess for known hypersensitivity to human immunoglobulins or any component of the formulation. - Use caution in patients with a history of cardiovascular disease or fluid overload. - Monitor renal function, especially in individuals with pre‑existing kidney disease. - Avoid rapid infusion rates; follow recommended administration guidelines. - Counsel pregnant or breastfeeding women of unknown safety profile and document risk‑benefit assessment. - Keep the product refrigerated and protect from light until use.

Hepatect Cp may interact with other medications or clinical conditions. Awareness of potential interactions helps ensure safe administration.

Avoid: - Concurrent use of other blood‑derived products without medical supervision. - Administration with live vaccines during the same visit.

Use with caution: - Concurrent anticoagulant therapy, as immunoglobulins can affect coagulation parameters. - Immunosuppressive agents that may alter the patient’s response to passive immunity. - High‑dose intravenous immunoglobulin therapy for other indications, which may increase risk of renal dysfunction. - Medications that affect renal clearance, requiring close monitoring of kidney function.